These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16470373)

  • 21. Lucio's phenomenon: exuberant case report and review of Brazilian cases.
    Rocha RH; Emerich PS; Diniz LM; Oliveira MB; Cabral AN; Amaral AC
    An Bras Dermatol; 2016; 91(5 suppl 1):60-63. PubMed ID: 28300896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies thrombotic syndrome misdiagnosed as Lucio's phenomenon.
    Bakos L; Correa CC; Bergmann L; Bonamigo RR; Muller LF
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):320-3. PubMed ID: 8862268
    [No Abstract]   [Full Text] [Related]  

  • 23. Ulcers in leprosy patients, an unrecognized clinical manifestation: a report of 8 cases.
    Miyashiro D; Cardona C; Valente NYS; Avancini J; Benard G; Trindade MAB
    BMC Infect Dis; 2019 Nov; 19(1):1013. PubMed ID: 31783808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lucio's phenomenon/erythema necroticans.
    Sehgal VN
    Int J Dermatol; 2005 Jul; 44(7):602-5. PubMed ID: 15985035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis.
    Tajima C; Suzuki Y; Mizushima Y; Ichikawa Y
    J Rheumatol; 1998 Sep; 25(9):1730-6. PubMed ID: 9733453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.
    Atanassova PA
    Yonsei Med J; 2007 Dec; 48(6):901-26. PubMed ID: 18159581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fatal case of Lucio phenomenon from India.
    Kumari R; Thappa DM; Basu D
    Dermatol Online J; 2008 Feb; 14(2):10. PubMed ID: 18700113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and histologic variations among thirty patients with Lucio's phenomenon and pure and primitive diffuse lepromatosis (Latapi's lepromatosis).
    Rea TH; Jerskey RS
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):169-88. PubMed ID: 16830639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lucio's phenomenon: clinical and therapeutic aspects.
    Souza CS; Roselino AM; Figueiredo F; Foss NT
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):417-25. PubMed ID: 11336069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasculitis in antiphospholipid syndrome.
    Lally L; Sammaritano LR
    Rheum Dis Clin North Am; 2015; 41(1):109-23, ix. PubMed ID: 25399943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interesting case of Lucio phenomenon triggered by activation of hepatitis C infection.
    Mareen J; Madhukara J
    Indian Dermatol Online J; 2016; 7(5):406-409. PubMed ID: 27730040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lucio phenomenon and Lucio leprosy.
    Kaur C; Thami GP; Mohan H
    Clin Exp Dermatol; 2005 Sep; 30(5):525-7. PubMed ID: 16045685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lepromatous leprosy with Lucio's phenomenon.
    Wang YF; Wang P; Huang H
    Australas J Dermatol; 2018 Feb; 59(1):62-63. PubMed ID: 28660648
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.
    Rees JD; Lança S; Marques PV; Gómez-Puerta JA; Moco R; Oliveri C; Khamashta MA; Hughes GR; D'Cruz DP
    Ann Rheum Dis; 2006 Jan; 65(1):109-11. PubMed ID: 16344494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near fatal case of Lucio leprosy with Lucio phenomenon with pleomorphic features and its successful management from a non-endemic area.
    Daniel SJ; Rajan M; Ruba MV; Aravamuthan R
    BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 38955383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lucio's phenomenon.
    Pursley TV; Jacobson RR
    Arch Dermatol; 1980 Feb; 116(2):201-4. PubMed ID: 7356353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse multibacillary leprosy patient with Lucio's phenomenon and positive anticardiolipin antibody misdiagnosed as lupus erythematosus panniculitis in the People's Republic of China.
    Gao W; Chen Z; Jiang H; Shi Y; Zhang W; Wang H
    Infect Drug Resist; 2019; 12():741-744. PubMed ID: 31114260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it Lucio leprosy with Lucio phenomenon or something else?
    Thappa DM; Karthikeyan K; Kumar BJ
    Indian J Lepr; 2002; 74(2):161-6. PubMed ID: 12708736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.